Patent · US Active

Post-batching CMA dosing into concrete

US10329202B2 · kind B2 · utility

4Cited by
25References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 1, 2016
Grant dateJun 25, 2019
Priority date
Expiry dateJun 19, 2037

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB28C7/024
  • WIPO fieldMaterials, metallurgy
  • WIPO sectorChemistry

Abstract

Disclosed are dosing methods for mitigating the deleterious effect of clays, which are born or conveyed by sand aggregates, crushed rock, gravel, and other aggregates used in the manufacture of concrete, upon the dosage efficiency of cement dispersants added into concrete. Instead of introducing the entire cement mitigation agent (CMA) into the aggregate material at a quarry or upon batching in the mix plant in a singular, upfront dose, the present invention comprises combining at least 51% and up to 100%, and, most preferably, at least 75% and up to 100%, of the total dosage amount of the CMAs into a given concrete mix batch during the transit portion of the delivery between initial batching at the mix plant and the pour event at the job site.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.